At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 10 enrolled
Drug / intervention
Provision of experimental honeybiological
Likely dose
Provision of experimental honey 25gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of Ethiopian Honey: Botanical Origin, Physicochemical, Antioxidant, Microbial Quality, Glycemic Index and Sensory Properties
In Brief
A Early Phase 1 clinical trial evaluating Provision of experimental honey for Hyperglycemia, Postprandial. Completed, enrolled 10 participants.
Detailed Summary
The purpose of this study is to determine which of the Ethiopian honeys slowly/rapidly raise the blood glucose level.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperglycemia, Postprandial
Countries--
Collaborators--
Timeline
Early Ph 1CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJul 2015
Primary CompletionNov 2015
Study CompletionFeb 2016
TodayJul 2026
First PostedJul 2, 2015
Enrollment StartJun 1, 2015
Primary CompletionNov 1, 2015
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11 years ago
Interventions
Provision of experimental honeybiological
Acacia, Becium grandiflorum, Croton macrostachys, Eucalyptus globules, Hypoestes, Leaucas abyssinica, Schefflera abyssinica, Syzygium guineense and reference glucose were used as test food. 25g available carbohydrate of the test food was provided to ten human subjects after fasted for 11 hours overnight.